title: PDGF stimulation of Müller cell proliferation: Contributions of c-JNK and the PI3K/Akt pathway.
abstract: Platelet-derived growth factor (PDGF) has a critical role in proliferative vitreoretinopathy (PVR) as a chemoattractant and mitogen for retinal pigment epithelial cells and retinal glial cells. Here, we investigated the potential effects of PDGF on the proliferation of Müller cells and the intracellular signaling pathway mediating these changes. PDGF induced Müller cell proliferation and increased phosphorylation of the PDGF receptor (PDGFR), as shown by an MTT assay and immunoprecipitation analyses. Both effects were blocked by JNJ, a PDGFR-selective tyrosine kinase inhibitor. PDGF also stimulated phosphorylation of c-JNK and Akt. PDGF-induced Müller cell proliferation was significantly reduced by pre-treatment with SP600125 and LY294002, inhibitors of c-JNK and Akt phosphorylation, respectively. Our findings collectively indicate that PDGF-stimulated Müller cell proliferation occurs via activation of the c-JNK and PI3K/Akt signaling pathways. These data provide useful information in establishing the role of Müller cells in the development of proliferative vitreoretinopathy.
authors: Department of Ophthalmology, Seoul Paik Hospital, Inje University College of Medicine, Busan, Republic of Korea.
authors: Sang Woong
authors: SW
authors: Moon
authors: Eun Jee
authors: EJ
authors: Chung
authors: Sun-Ah
authors: SA
authors: Jung
authors: Joon H
authors: JH
authors: Lee
mesh_terms: D000818:Animals; D000873:Anthracenes / Q000494:pharmacology; D049109:Cell Proliferation; D002867:Chromones / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D048031:JNK Mitogen-Activated Protein Kinases / Q000037:antagonists & inhibitors / Q000502:physiology*; D009025:Morpholines / Q000494:pharmacology; D019869:Phosphatidylinositol 3-Kinases / Q000502:physiology*; D000081082:Phosphoinositide-3 Kinase Inhibitors; D010982:Platelet-Derived Growth Factor / Q000494:pharmacology / Q000502:physiology*; D051057:Proto-Oncogene Proteins c-akt / Q000037:antagonists & inhibitors / Q000502:physiology*; D051381:Rats; D011914:Rats, Inbred BN; D017479:Receptors, Platelet-Derived Growth Factor / Q000819:agonists / Q000378:metabolism; D012160:Retina / Q000378:metabolism / Q000473:pathology*; D018630:Vitreoretinopathy, Proliferative / Q000378:metabolism / Q000473:pathology*
chemical_list: D000873:Anthracenes; D002867:Chromones; D004791:Enzyme Inhibitors; D048031:JNK Mitogen-Activated Protein Kinases; D009025:Morpholines; D019869:Phosphatidylinositol 3-Kinases; D000081082:Phosphoinositide-3 Kinase Inhibitors; D010982:Platelet-Derived Growth Factor; D051057:Proto-Oncogene Proteins c-akt; D017479:Receptors, Platelet-Derived Growth Factor; C432165:pyrazolanthrone; C085911:2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one